Literature DB >> 15096593

Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver.

Pawel Dobrzyn1, Agnieszka Dobrzyn, Makoto Miyazaki, Paul Cohen, Esra Asilmaz, D Grahame Hardie, Jeffrey M Friedman, James M Ntambi.   

Abstract

Stearoyl-CoA desaturase (SCD) catalyzes the rate-limiting step in the biosynthesis of monounsaturated fatty acids. Mice with a targeted disruption of the SCD1 isoform have reduced body adiposity, increased energy expenditure, and up-regulated expression of several genes encoding enzymes of fatty acid beta-oxidation in liver. The mechanisms by which SCD deficiency leads to these metabolic changes are presently unknown. Here we show that the phosphorylation and activity of AMP-activated protein kinase (AMPK), a metabolic sensor that regulates lipid metabolism during increased energy expenditure is significantly increased (approximately 40%, P < 0.01) in liver of SCD1 knockout mice (SCD1-/-). In parallel with the activation of AMPK, the phosphorylation of acetyl-CoA carboxylase at Ser-79 was increased and enzymatic activity was decreased (approximately 35%, P < 0.001), resulting in decreased intracellular levels of malonyl-CoA (approximately 47%, P < 0.001). An SCD1 mutation also increased AMPK phosphorylation and activity and increased acetyl-CoA carboxylase phosphorylation in leptin-deficient ob/ob mice. Lower malonyl-CoA concentrations are known to derepress carnitine palmitoyltransferase 1 (CPT1). In SCD1-/- mice, CPT1 and CPT2 activities were significantly increased (in both cases approximately 60%, P < 0.001) thereby stimulating the oxidation of mitochondrial palmitoyl-CoA. Our results identify AMPK as a mediator of increased fatty acid oxidation in liver of SCD1-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096593      PMCID: PMC404058          DOI: 10.1073/pnas.0401627101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors.

Authors:  W Yang; Y H Hong; X Q Shen; C Frankowski; H S Camp; T Leff
Journal:  J Biol Chem       Date:  2001-08-22       Impact factor: 5.157

2.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

3.  Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.

Authors:  Hideyuki Sakoda; Takehide Ogihara; Motonobu Anai; Midori Fujishiro; Hiraku Ono; Yukiko Onishi; Hideki Katagiri; Miho Abe; Yasushi Fukushima; Nobuhiro Shojima; Kouichi Inukai; Masatoshi Kikuchi; Yoshitomo Oka; Tomoichiro Asano
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-06       Impact factor: 4.310

4.  Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase.

Authors:  Takumi Kawaguchi; Kiyoshi Osatomi; Hiromi Yamashita; Tsutomu Kabashima; Kosaku Uyeda
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

5.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  Yasuhiko Minokoshi; Young-Bum Kim; Odile D Peroni; Lee G D Fryer; Corinna Müller; David Carling; Barbara B Kahn
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

6.  The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1.

Authors:  M Miyazaki; Y C Kim; M P Gray-Keller; A D Attie; J M Ntambi
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

Review 7.  Fatty acid import into mitochondria.

Authors:  J Kerner; C Hoppel
Journal:  Biochim Biophys Acta       Date:  2000-06-26

8.  Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid.

Authors:  M Miyazaki; W C Man; J M Ntambi
Journal:  J Nutr       Date:  2001-09       Impact factor: 4.798

9.  Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.

Authors:  L Abu-Elheiga; M M Matzuk; K A Abo-Hashema; S J Wakil
Journal:  Science       Date:  2001-03-30       Impact factor: 47.728

10.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

View more
  132 in total

1.  Differential effects of hypothalamic long-chain fatty acid infusions on suppression of hepatic glucose production.

Authors:  R A Ross; L Rossetti; T K T Lam; G J Schwartz
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-20       Impact factor: 4.310

2.  Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma.

Authors:  Arvin M Gouw; Livia S Eberlin; Katherine Margulis; Delaney K Sullivan; Georgia G Toal; Ling Tong; Richard N Zare; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-11       Impact factor: 11.205

3.  Characterization of human SCD2, an oligomeric desaturase with improved stability and enzyme activity by cross-linking in intact cells.

Authors:  Shaobo Zhang; Yanzhu Yang; Yuguang Shi
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 4.  Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.

Authors:  Jun Kusunoki; Akio Kanatani; David E Moller
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

5.  Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; Monica L Kearney; Jacqueline M Crissey; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

6.  Quantitative lipid metabolomic changes in alcoholic micropigs with fatty liver disease.

Authors:  Angela M Zivkovic; J Bruce German; Farah Esfandiari; Charles H Halsted
Journal:  Alcohol Clin Exp Res       Date:  2009-01-21       Impact factor: 3.455

Review 7.  Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.

Authors:  Simon Ducheix; Maria Carmela Vegliante; Gaetano Villani; Nicola Napoli; Carlo Sabbà; Antonio Moschetta
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

8.  Exercise training decreases hepatic SCD-1 gene expression and protein content in rats.

Authors:  Siham Yasari; Denis Prud'homme; Donghao Wang; Marek Jankowski; Emile Levy; Jolanta Gutkowska; Jean-Marc Lavoie
Journal:  Mol Cell Biochem       Date:  2009-09-24       Impact factor: 3.396

Review 9.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.

Authors:  N Stefan; A Peter; A Cegan; H Staiger; J Machann; F Schick; C D Claussen; A Fritsche; H-U Häring; E Schleicher
Journal:  Diabetologia       Date:  2008-02-20       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.